MedTrace Logo

The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System

NCT01206933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-02-10

No results posted yet for this study

Summary

Investigators in the Division of Infectious Diseases and the Departments of Biochemistry and Molecular Biology of The George Washington University Medical Center are carrying out a research study to determine why patients with Human Immunodeficiency Virus (HIV) and Hepatitis C virus (HCV) co-infection (HIV/HCV) have a more rapid and progressive course of HCV infection, leading to fatty infiltration of the liver and cirrhosis.

Conditions

  • Human Immunodeficiency Virus (HIV)
  • Hepatitis C, Chronic

Sponsors & Collaborators

  • George Washington University

    lead OTHER

Principal Investigators

  • David Parenti, MD · George Washington University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01206933 on ClinicalTrials.gov